Can algae contribute to the war with Covid-19?

References

• Guo Y-R, Cao Q-D, Hong Z-S, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak– an update on the status. Mil Med Res. 2020;7(1):1–10.
   PubMed Web of Science ®Google Scholar
• Elengoe A. COVID-19 Outbreak in Malaysia. Osong Public Health Res Perspect. 2020;11(3):93–100.
   PubMedGoogle Scholar
• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
   PubMed Web of Science ®Google Scholar
• World Health Organization, Archived: WHO timeline - COVID-19, 2020.
   Google Scholar
• Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970–971.
   PubMed Web of Science ®Google Scholar
• Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281–286.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Mckeever A, Dozens of COVID-19 vaccines are in development. Here are the ones to follow, National Geographic, 2020.
   Google Scholar
• Rosales-Mendoza S, García-Silva I, González-Ortega O, et al. The potential of algal biotechnology to produce antiviral compounds and biopharmaceuticals. Molecules. 2020;25(18):4049.
   PubMed Web of Science ®Google Scholar
• Chew KW, Yap JY, Show PL, et al. Microalgae biorefinery: high value products perspectives. Bioresour Technol. 2017;229:53–62.
   PubMed Web of Science ®Google Scholar
• Siddiqui A, Wei Z, Boehm M, et al. Engineering microalgae through chloroplast transformation to produce high-value industrial products. Biotechnol Appl Biochem. 2020;67(1):30–40.
   PubMed Web of Science ®Google Scholar
• De Morais MG, Vaz BDS, De Morais EG, et al. Biologically active metabolites synthesized by microalgae. Biomed Res Int. 2015;2015:1–15.
   Web of Science ®Google Scholar
• Gimpel JA, Henríquez V, Mayfield SP. In metabolic engineering of eukaryotic microalgae: potential and challenges come with great diversity. Front Microbiol. 2015;6:1376.
   PubMed Web of Science ®Google Scholar
• Lauritano C, Ferrante MI, Rogato A. Marine natural products from microalgae: an -omics overview. Mar Drugs. 2019;17(5):269.
   PubMed Web of Science ®Google Scholar
• Tang DYY, Khoo KS, Chew KW, et al. Potential utilization of bioproducts from microalgae for the quality enhancement of natural products. Bioresour Technol. 2020;304:122997.
   PubMed Web of Science ®Google Scholar
• Tang DYY, Yew GY, Koyande AK, et al. Green technology for the industrial production of biofuels and bioproducts from microalgae: a review. Environ Chem Lett. 2020;18(6):1967–1985.
   Web of Science ®Google Scholar
• Deig EF, Ehresmann DW, Hatch MT, et al. Inhibition of herpesvirus replication by marine algae extracts. Antimicrob Agents Chemother. 1974;6(4):524.
   PubMed Web of Science ®Google Scholar
• Sami N, Ahmad R, Fatma T. Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2. Biomed J. 2020. DOI:10.1016/j.bj.2020.11.014
   PubMed Web of Science ®Google Scholar
• Kwon PS, Oh H, Kwon S-J, et al. Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro. Cell Discov. 2020;6(1):50.
   PubMed Web of Science ®Google Scholar
• Cian RLE, López-Posadas RO, Drago SR, et al. Immunomodulatory properties of the protein fraction from Phorphyra columbina. J Agric Food Chem. 2012;60(33):8146–8154.
   PubMed Web of Science ®Google Scholar
• Tzachor A, Rozen O, Khatib S, et al. Photosynthetically controlled spirulina, but not solar spirulina, inhibits TNF-α secretion: potential implications for COVID-19-related cytokine storm therapy. Mar Biotechnol. 2021;23(1):149–155.
   PubMed Web of Science ®Google Scholar
• Robinson PC, Richards D, Tanner HL, et al. Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment. Lancet Rheumatol. 2020;2(11):e653–e655.
   PubMedGoogle Scholar
• Ratha SK, Renuka N, Rawat I, et al. Prospective options of algae-derived nutraceuticals as supplements to combat COVID-19 and human coronavirus diseases. Nutrition. 2021;83:111089.
   PubMed Web of Science ®Google Scholar
• Chu W, Algae extract may act to slow down COVID progression, say researchers, NutraIngredients, 2021.
   Google Scholar
• Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034.
   PubMed Web of Science ®Google Scholar
• Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–848.
   PubMed Web of Science ®Google Scholar
• McGonagle D, Sharif K, O’Regan A, et al. The role of cytokines including interleukin-6 in COVID-19 induced Pneumonia and Macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6):102537.
   PubMed Web of Science ®Google Scholar
• Bastos M, Tavaziva G, Abidi S, et al. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. BMJ. 2020;370:m2516.
   PubMedGoogle Scholar
• Maxmen A. The researchers taking a gamble with antibody tests for coronavirus. Nat (Lond.). 2020. DOI:10.1038/d41586-020-01163-5.
   Google Scholar
• Mahmud F, Bangladesh scientists create $3 kit. Can it help detect COVID-19?, Al Jazeera, 2020.
   Google Scholar
• Berndt A, Smalley T, Ren B, et al. Recombinant production of a functional SARS-CoV-2 spike receptor binding domain in the green algae Chlamydomonas reinhardtii. bioRxiv; 2021.
   Google Scholar
• Thanh Le T, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305–306.
   PubMed Web of Science ®Google Scholar
• C.f.D.C.a. Prevention., Different COVID-19 Vaccines, United States, 2021.
   Google Scholar
• Specht E, Miyake-Stoner S, Mayfield S. Micro-algae come of age as a platform for recombinant protein production. Biotechnol Lett. 2010;32(10):1373–1383.
   PubMed Web of Science ®Google Scholar
• Soccol CR, Pandey A, Larroche C. Fermentation processes engineering in the food industry. CRC Press; 2013.
   Google Scholar
• Spicer A, Molnar A. Gene editing of Microalgae: scientific progress and regulatory challenges in Europe. Biology (Basel). 2018;7.
   PubMedGoogle Scholar
• Fayyaz M, Chew KW, Show PL, et al. Genetic engineering of microalgae for enhanced biorefinery capabilities. Biotechnol Adv. 2020;43:107554.
   PubMed Web of Science ®Google Scholar
• Specht EA, Mayfield SP. Algae-based oral recombinant vaccines. Front Microbiol. 2014;5:60.
   PubMed Web of Science ®Google Scholar
• Gunasekaran B, Gothandam K. A review on edible vaccines and their prospects. Braz J Med Biol Res. 2020;53(2). DOI:10.1590/1414-431x20198749
   PubMed Web of Science ®Google Scholar
• Gressel D. Using algae to make a vaccine against COVID-19. RealClear Health; 2020.
   Google Scholar
• Ramus J. Cell surface polysaccharides of the red alga Porphyridium. In Loewus K, editor. Biogenesis of Plant Cell Wall Polysaccharides. Academic Press; 1973. p. 333–359
   Google Scholar
• Bansal S, Jonsson CB, Taylor SL, et al. Iota-carrageenan and xylitol inhibit SARS-CoV-2 in cell culture. bioRxiv; 2020.
   Google Scholar
• Eccles R, Meier C, Jawad M, et al. Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold. Respir Res. 2010;11(1):1–10.
   PubMedGoogle Scholar
• Koenighofer M, Lion T, Bodenteich A, et al. Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials. Multidiscip Respir Med. 2014;9:1–12.
   PubMedGoogle Scholar
• Leibbrandt A, Meier C, König-Schuster M, et al. Iota-carrageenan is a potent inhibitor of influenza A virus infection. PloS One. 2010;5(12):e14320.
   PubMed Web of Science ®Google Scholar
• Allegretto-Pitt A. Formula developed to combat HIV could work as novel coronavirus preventive. Pittsburgh:University of Pittsburgh; 2020.
   Google Scholar
• PTI, Covid-19: new algae-based respirator may help people wearing masks breath easy, The Economic Times, 2020.
   Google Scholar
• Koyande AK, Chew KW, Rambabu K, et al. Microalgae: a potential alternative to health supplementation for humans. Food Sci Hum Wellness. 2019;8(1):16–24.
   Google Scholar
• Talukdar J, Bhadra B, Dattaroy T, et al. Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19. Biomed Pharmacother. 2020;132:110886. doi:10.1016/j.biopha.2020.110886
   Google Scholar
• Lam SK, Ng TB. Lectins: production and practical applications. Appl Microbiol Biotechnol. 2011;89(1):45–55.
   PubMed Web of Science ®Google Scholar
• Ruocco N, Costantini S, Guariniello S, et al. Polysaccharides from the marine environment with pharmacological, cosmeceutical and nutraceutical potential. Molecules. 2016;21(5):551.
   PubMed Web of Science ®Google Scholar
• Lee Y-E, Kim H, Seo C, et al. Marine polysaccharides: therapeutic efficacy and biomedical applications. Arch Pharm Res. 2017;40(9):1006–1020.
   PubMed Web of Science ®Google Scholar
• Norero D, Italy and Israel bet on GM microalgae to develop edible COVID vaccine, Genetic Literacy Project, 2020.
   Google Scholar
• Nagle V, Gaikwad M, Pawar Y, et al. Marine red alga Porphyridium sp. as a source of Sulfated Polysaccharides (SPs) for combating against COVID-19. Preprints; 2020. p. 2020040168.
   Google Scholar